BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 28, 2025
Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

New MRI can 'see through' metal screws after hip surgery

March 17, 2014
By Amanda Pedersen
People who sustain the most common type of hip fracture, known as a femoral neck fracture, are at increased risk of complications. A special type of MRI developed at Hospital for Special Surgery (New York) in collaboration with GE Healthcare (Chalfont, UK) can show a detailed image following fracture repair, without the distortion caused by metal surgical screws that are problematic in standard MRIs.
Read More

Robotic FloShield to enhance vision with Intuitive's da Vinci

March 14, 2014
By Amanda Pedersen

Teva launches new drug-device for schizophrenia and bipolar I

March 12, 2014
By Amanda Pedersen

Financings roundup: Med-tech hits a daily double as two device companies file for IPOs

March 12, 2014
By Amanda Pedersen
Initial public offerings have almost become a thing of the past for the medical device industry, but two device companies are going against the grain. TriVascular Technologies (Santa Rosa, California) and Lombard Medical Technologies (London and Irvine, California) both filed IPO paperwork Monday. Both companies sell devices to treat abdominal aortic aneurysms.
Read More

MDD's Cardiology Extra

March 11, 2014
By Amanda Pedersen

NewCo on the Go: Medallion Therapeutics to offer targeted drug delivery devices

March 10, 2014
By Amanda Pedersen

AHA/ACC update guidelines for valvular heart disease

March 5, 2014
By Amanda Pedersen
Patients with valvular heart disease (VHD) will now be classified by four stages of progression, similar to heart failure patients, according to new practice guidelines from the American Heart Association (AHA; Dallas) and the American College of Cardiology (ACC; Washington). The new guidelines also lower the threshold for interventions, including, for the first time, transcatheter as well as surgical interventions.
Read More

MDD's Cardiology Extra

March 4, 2014
By Amanda Pedersen

Financings Roundup: Invuity secures up to $36M in 'E' financing for illumination tech

March 4, 2014
By Amanda Pedersen

BD gets FDA 510(k) and CLIA waiver for Group A Strep test

Feb. 28, 2014
By Amanda Pedersen
Previous 1 2 … 65 66 67 68 69 70 71 72 73 … 222 223 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 24, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 24, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Illustration of tau accumulating in a neuron cell.

    ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

    BioWorld
    ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing